Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Rogge

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Biopharmaceutics & Drug Disposition|September 1, 1987
Single dose and steady-state pharmacokinetics of adinazolam after oral administration to manJ G Wagner, M C Rogge, R B Natale, et al.
Journal of Clinical Pharmacology|December 1, 1993
Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profilesW N Charman, M C Rogge, A W Boddy, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2006
Bioavailability and relative tissue distribution of [125I]-recombinant human thrombin following intravenous or subcutaneous administration to non-human primatesJ E Visich, K A Byrnes-Blake, K B Lewis, et al.
Drug Delivery|July 3, 2009
Impaired bioavailability of interferon beta-1a when administered intramuscularly by needle-free injectionM C Rogge, S Charenkavanich, M DiBiase, et al.
Journal of Clinical Pharmacy and Therapeutics|February 16, 2002
Absence of a pharmacokinetic interaction between digoxin and levofloxacinS C Chien, M C Rogge, R R Williams, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline dispositionM C Rogge, W R Solomon, A J Sedman, et al.
Pharmaceutical Research|January 1, 1992
Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compoundS A Charman, W N Charman, M C Rogge, et al.
Clinical Pharmacology and Therapeutics|October 1, 1989
The theophylline-enoxacin interaction: II. Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacinM C Rogge, W R Solomon, A J Sedman, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1989
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drugM G Woods, G D Diana, M C Rogge, et al.
Journal of Pharmaceutical Sciences|March 1, 1984
Bioavailability of hydrochlorothiazide from tablets and suspensionsR B Patel, U R Patel, M C Rogge, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biopharmaceutics & Drug Disposition|September 1, 1987
Single dose and steady-state pharmacokinetics of adinazolam after oral administration to manJ G Wagner, M C Rogge, R B Natale, et al.
Journal of Clinical Pharmacology|December 1, 1993
Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profilesW N Charman, M C Rogge, A W Boddy, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2006
Bioavailability and relative tissue distribution of [125I]-recombinant human thrombin following intravenous or subcutaneous administration to non-human primatesJ E Visich, K A Byrnes-Blake, K B Lewis, et al.
Drug Delivery|July 3, 2009
Impaired bioavailability of interferon beta-1a when administered intramuscularly by needle-free injectionM C Rogge, S Charenkavanich, M DiBiase, et al.
Journal of Clinical Pharmacy and Therapeutics|February 16, 2002
Absence of a pharmacokinetic interaction between digoxin and levofloxacinS C Chien, M C Rogge, R R Williams, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline dispositionM C Rogge, W R Solomon, A J Sedman, et al.
Pharmaceutical Research|January 1, 1992
Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compoundS A Charman, W N Charman, M C Rogge, et al.
Clinical Pharmacology and Therapeutics|October 1, 1989
The theophylline-enoxacin interaction: II. Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacinM C Rogge, W R Solomon, A J Sedman, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1989
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drugM G Woods, G D Diana, M C Rogge, et al.
Journal of Pharmaceutical Sciences|March 1, 1984
Bioavailability of hydrochlorothiazide from tablets and suspensionsR B Patel, U R Patel, M C Rogge, et al.
Pageof 3